RA, B., M, A., S, A., OS, A., M, A., B, K., . . . H, A. (2026). Efficacy and safety of apixaban versus warfarin in new-onset atrial fibrillation post coronary artery bypass grafting: A retrospective cohort study. Medicine, 105(28), e49695. https://doi.org/10.1097/MD.0000000000049695
Chicago Style (17th ed.) CitationRA, Bukhari, Almutairi M, Alraddadi S, Alkhezi OS, Alomran M, Kumar B, Alrasheed MA, and Almodaimegh H. "Efficacy and Safety of Apixaban Versus Warfarin in New-onset Atrial Fibrillation Post Coronary Artery Bypass Grafting: A Retrospective Cohort Study." Medicine 105, no. 28 (2026): e49695. https://doi.org/10.1097/MD.0000000000049695.
MLA (9th ed.) CitationRA, Bukhari, et al. "Efficacy and Safety of Apixaban Versus Warfarin in New-onset Atrial Fibrillation Post Coronary Artery Bypass Grafting: A Retrospective Cohort Study." Medicine, vol. 105, no. 28, 2026, p. e49695, https://doi.org/10.1097/MD.0000000000049695.